KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring KRASG12C mutation Meeting Abstract
| Authors: | Riely, G. J.; Ou, S. H. I.; Rybkin, I.; Spira, A.; Papadopoulos, K.; Sabari, J. K.; Johnson, M.; Heist, R. S.; Bazhenova, L.; Barve, M.; Pacheco, J. M.; Velastegui, K.; Cilliers, C.; Olson, P.; Christensen, J. G.; Kheoh, T.; Chao, R. C.; Jänne, P. A. |
| Abstract Title: | KRYSTAL-1: Activity and preliminary pharmacodynamic (PD) analysis of adagrasib (MRTX849) in patients (pts) with advanced non-small cell lung cancer (NSCLC) harboring KRASG12C mutation |
| Meeting Title: | European Lung Cancer Virtual Congress (ELCC 2021 Virtual) |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 16 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2021 Mar 25-27 |
| Meeting Location: | Virtual Conference |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2021-04-01 |
| Start Page: | S751 |
| End Page: | S752 |
| Language: | English |
| ACCESSION: | WOS:000634855900100 |
| PROVIDER: | wos |
| DOI: | 10.1016/S1556-0864(21)01941-9 |
| Notes: | Meeting Abstract: 99O_PR -- Source: Wos |
